Rituximab retherapy in aggressive non Hodgkin lymphoma after inital immunochemotherapeutic treatment with rituximab

被引：0
|
作者：
Borgerding, A. [1 ]
Hasenkamp, J. [1 ]
Truemper, L. [1 ]
Glass, B. [2 ]
机构：
[1] Univ Hosp, Gottingen, Germany
[2] Asklepios Klin St Georg, Dept Hematol, Hamburg, Germany
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：220 / 221
页数：2
相关论文
共 50 条
  • [41] HBV reactivation in HBSAG negative patient after rituximab therapy for non hodgkin lymphoma
    Pezzullo, L.
    Amitrano, L.
    Bene, L.
    Rocco, S.
    Finizio, O.
    Ferrara, M. G.
    Buonanno, M. T.
    Nunziata, G.
    Mettivier, L.
    Mettivier, V
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 157 - 157
  • [42] RESULTS OF MAINTENANCE THERAPY WITH RITUXIMAB IN FOLLICULAR NON HODGKIN LYMPHOMA
    Soria, B.
    Olave, M. T.
    Rubio-Escuin, R.
    Rubio-Martinez, A.
    Palomera, L.
    Fuertes, M. A.
    Mayayo, P.
    Recasens, V.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 112 - 112
  • [43] Rituximab: An innovative therapy for non-Hodgkin's lymphoma
    Wood, AM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (03) : 215 - 229
  • [44] Impact of Rituximab in FEAM conditioning regimen for non Hodgkin Lymphoma
    Mazziotta, F.
    Mazziotta, Francesco
    Orciuolo, Enrico
    Bozzoli, Valentina
    Buda, Gabriele
    Messa, Anna Rita
    Iovino, Lorenzo
    Forese, Pasquale
    Ghio, Francesco
    Dargenio, Michela
    Matera, Rossella
    Renzo, Nicola Di
    Petrini, Mario
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5588 - 5589
  • [45] Prolonged Hypogammaglobulinemia Following Rituximab Treatment for Non-Hodgkin's Lymphoma Disease
    Hannouch, Kristine
    McGoey, Barbara
    Michelis, Mary Ann
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 385 - 385
  • [46] Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma
    Mielke, F.
    Schneider-Obermeyer, J.
    Doerner, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) : 1056 - 1057
  • [47] RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA
    Scigliano, E.
    Grosskreutz, C. L.
    Osman, K.
    Malone, A.
    Nieto, J.
    Isola, L. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S208 - S209
  • [48] Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance
    Julia Horn
    Martina Kleber
    Stefanie Hieke
    Annette Schmitt-Gräff
    Ralph Wäsch
    Monika Engelhardt
    Annals of Hematology, 2012, 91 : 1579 - 1586
  • [49] Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance
    Horn, Julia
    Kleber, Martina
    Hieke, Stefanie
    Schmitt-Graeff, Annette
    Waesch, Ralph
    Engelhardt, Monika
    ANNALS OF HEMATOLOGY, 2012, 91 (10) : 1579 - 1586
  • [50] Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Harting, Rekha
    Venugopal, Pararneswaran
    Gregory, Stephanie A.
    O'Brien, Teresa
    Bogdanova, Elena
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (06): : 406 - 412
12345